These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 15745782)

  • 21. Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.
    Shah SU; Shields CL; Bianciotto C; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2012 Apr; 119(4):838-842.e2. PubMed ID: 22133794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of Iodine-125 radiotherapy in the treatment of uveal melanoma].
    Caminal Mitjana JM; Quintana Casany M; Pera Fábregas J; Cinos Cope C; Guedea F
    Arch Soc Esp Oftalmol; 2002 Jan; 77(1):29-38. PubMed ID: 11813118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control.
    Quivey JM; Augsburger J; Snelling L; Brady LW
    Cancer; 1996 Jun; 77(11):2356-62. PubMed ID: 8635107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 125I plaque brachytherapy for anterior uveal melanomas.
    Lumbroso-Le Rouic L; Charif Chefchaouni M; Levy C; Plancher C; Dendale R; Asselain B; Solignac S; Mazal A; Desjardins L
    Eye (Lond); 2004 Sep; 18(9):911-6. PubMed ID: 15002010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Late complications after brachytherapy of I-125 uveal melanoma].
    Kowal J; Romanowska-Dixon B
    Klin Oczna; 2016; 118(3):226-30. PubMed ID: 30088387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tyndallometry for follow-up of iodine-125 brachytherapy of uveal malignant melanomas. Report of 2 patients].
    Nguyen NX; Küchle M; Strunk W
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):25-30. PubMed ID: 8965473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Panretinal photocoagulation for radiation-induced ocular ischemia.
    Augsburger JJ; Roth SE; Magargal LE; Shields JA
    Ophthalmic Surg; 1987 Aug; 18(8):589-93. PubMed ID: 3658314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular complications following I-125 brachytherapy for choroidal melanoma.
    Wen JC; Oliver SC; McCannel TA
    Eye (Lond); 2009 Jun; 23(6):1254-68. PubMed ID: 19265865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
    Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
    J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up after uveal melanoma charged particle therapy.
    Char DH; Kroll SM; Castro J
    Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predictive of radiation retinopathy post (125)Iodine brachytherapy for uveal melanoma.
    Krema H; Xu W; Payne D; Vasquez LM; Pavlin CJ; Simpson R
    Can J Ophthalmol; 2011 Apr; 46(2):158-63. PubMed ID: 21708084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Radiation optic neuropathy after the brachytherapy of the uveal melanoma].
    Szuścik I; Romanowska-Dixon B; Markiewicz A; Pogrzebielski A; Jakubowska B
    Klin Oczna; 2006; 108(7-9):278-80. PubMed ID: 17290823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22.
    Collaborative Ocular Melanoma Study Group
    Ophthalmology; 2004 May; 111(5):966-76. PubMed ID: 15121376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for radiation maculopathy after ophthalmic plaque radiation for choroidal melanoma.
    Finger PT; Chin KJ; Yu GP;
    Am J Ophthalmol; 2010 Apr; 149(4):608-15. PubMed ID: 20138602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NEW ULTRA-WIDE-FIELD ANGIOGRAPHIC GRADING SCHEME FOR RADIATION RETINOPATHY AFTER IODINE-125 BRACHYTHERAPY FOR UVEAL MELANOMA.
    McCannel TA; Kim E; Kamrava M; Lamb J; Caprioli J; Yang D; McCannel CA
    Retina; 2018 Dec; 38(12):2415-2421. PubMed ID: 29016456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study.
    Sobrin L; Schiffman JC; Markoe AM; Murray TG
    Ophthalmology; 2005 Oct; 112(10):1777-83. PubMed ID: 16095708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-related lipid exudation and associated tumor-related complications after plaque radiotherapy of posterior uveal melanoma.
    Mashayekhi A; Tuncer S; Shields CL; Shields JA
    Eur J Ophthalmol; 2013; 23(3):399-409. PubMed ID: 23483500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructural alterations in extraocular muscles following iodine-125 brachytherapy for uveal melanoma.
    Kïratlï H; Yïlmaz PT; Sargon M
    Strabismus; 2007; 15(2):103-9. PubMed ID: 17564940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric and late radiation toxicity comparison between iodine-125 brachytherapy and stereotactic radiation therapy for juxtapapillary choroidal melanoma.
    Krema H; Heydarian M; Beiki-Ardakani A; Weisbrod D; Xu W; Laperriere NJ; Sahgal A
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):510-5. PubMed ID: 23507292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.